TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 51 filers reported holding TALARIS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,569 | -7.6% | 914,262 | 0.0% | 0.11% | +27.9% |
| Q2 2023 | $2,779 | +61.7% | 914,262 | 0.0% | 0.09% | -15.7% |
| Q1 2023 | $1,719 | -18.4% | 914,262 | -55.7% | 0.10% | -13.6% |
| Q4 2022 | $2,106 | -100.0% | 2,064,262 | 0.0% | 0.12% | -49.1% |
| Q3 2022 | $5,429,000 | -41.7% | 2,064,262 | 0.0% | 0.23% | -53.3% |
| Q2 2022 | $9,310,000 | -54.2% | 2,064,262 | 0.0% | 0.50% | -41.5% |
| Q1 2022 | $20,312,000 | -35.6% | 2,064,262 | 0.0% | 0.85% | -0.7% |
| Q4 2021 | $31,563,000 | +12.8% | 2,064,262 | 0.0% | 0.86% | +36.7% |
| Q3 2021 | $27,991,000 | -7.7% | 2,064,262 | 0.0% | 0.63% | +1.8% |
| Q2 2021 | $30,324,000 | – | 2,064,262 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |